ClinicalTrials.Veeva

Menu

Corticosteroids and / or Arthrographic Distention in the Treatment of Adhesive Capsulitis (CADAC)

I

Imelda Hospital, Bonheiden

Status

Unknown

Conditions

Frozen Shoulder
Adhesive Capsulitis

Treatments

Procedure: Arthrographic distention
Drug: Intra-articular corticosteroid Depo Medrol

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Arthrographic distention of the shoulder joint is an increasingly popular treatment option in the management of patients with frozen shoulder. Most have included the intra-articular injection of a corticosteroid as part of the procedure, but it is not known if this is necessary. It is also not known whether arthrographic distention using steroid and saline is better than intra-articular steroid injection alone.

The purpose of this study is to determine whether there is an additional benefit in the combination of arthrographic distention plus intra-articular corticosteroid injection compared to arthrographic distention or intra-articular corticosteroid injection alone.

Enrollment

132 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pain and stiffness in predominantly 1 shoulder for 4 weeks or longer
  • Restriction of passive motion of greater than 30° in 2 or more planes of movement (measured to onset of pain with goniometer)

Exclusion criteria

  • Previous arthrographic distention and/or corticosteroid injection
  • Systemic inflammatory joint disease
  • Radiological evidence of osteoarthritis of the shoulder or fracture
  • Signs of a complete rotator cuff tear
  • Contraindications to arthrogram and/or distention
  • Lack of written informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

132 participants in 3 patient groups

Arthrographic distention + intra-articular corticosteroid
Experimental group
Description:
Arthrographic distention of the glenohumeral joint with injection of 5 ml contrast, 1 ml (40 mg) Depo Medrol(Methylprednisolone Acetate Injectable Suspension), 15 ml local anaesthetic (Prilocaine) and up to 15 ml saline.
Treatment:
Procedure: Arthrographic distention
Drug: Intra-articular corticosteroid Depo Medrol
Arthrographic distention
Active Comparator group
Description:
Arthrographic distention of the glenohumeral joint with injection of 5 ml contrast, 15 ml local anaesthetic (Prilocaine) and up to 15 ml saline.
Treatment:
Procedure: Arthrographic distention
Intra-articular corticosteroid
Active Comparator group
Description:
Arthrographic pseudodistention of the glenohumeral joint with injection of 5 ml contrast and 1 ml (40 mg) Depo Medrol(Methylprednisolone Acetate Injectable Suspension).
Treatment:
Drug: Intra-articular corticosteroid Depo Medrol

Trial contacts and locations

1

Loading...

Central trial contact

Rolf Symons, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems